Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...

Medicare enrollees can receive coverage for ... heart attack and stroke. While Wegovy and Ozempic were both listed on the FDA’s drug shortage list, compounding pharmacies were able to sell ...

— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...